A comparison of ventral hernia repair with Strattice and Fortiva mesh.Primary The study team aims to determine the hernia recurrence rates for RTI Surgical biologic mesh (Fortiva) compared to Strattice. Also the study team aims to determine the mesh related complications for RTI Surgical biologic mesh (Fortiva) compared to Strattice
This study will be a prospective, matched study of patients using Fortiva biologic mesh to determine the rates of hernia recurrence and mesh related complication compared to Strattice mesh. Patients who meet the inclusion and exclusion criteria will be prospectively enrolled to receive a Ventral Hernia Repair (VHR) using Fortiva biologic mesh and will be compared to a retrospective cohort of patients with a VHR that utilized Strattice mesh. Patients will be propensity matched in a 1:3 (Fortiva : Strattice) fashion based on age, sex, and hernia defect size.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
6
Ventral hernia repair using Fortiva biologic mesh
Retrospective cohort of ventral hernia repair patients using Strattice mesh
Carolinas Medical Center
Charlotte, North Carolina, United States
Frequency of Participants With a Hernia Recurrence
Frequency of participants with a hernia recurrence
Time frame: 1 year follow up post surgical repair
Percentage of Participants With a Hernia Recurrence
Percentage of participants with a hernia recurrence
Time frame: 1 year follow up post surgical repair
Number of Participants With a Mesh Related Complication
Number of participants with a mesh related complication
Time frame: 1 year follow up post surgical repair
Percent of Participants With a Mesh Related Complication
Percent of participants with a mesh related complication
Time frame: 1 year follow up post surgical repair
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.